Stromal degradation by the malignant epithelium in pancreatic cancer and the therapeutic potential of proteolytic inhibition

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 5, Issue 4, 1998, Pages 392-401

  Bramhall, Simon R ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Marimastat; Matrix metalloproteinase; Pancreatic cancer; Treatment

Indexed keywords

CELL ADHESION MOLECULE; ENZYME INHIBITOR; HYDROXAMIC ACID; MARIMASTAT; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL; CLINICAL TRIAL; DRUG ANTAGONISM; ENZYMOLOGY; HUMAN; METABOLISM; PANCREAS TUMOR; PHYSIOLOGY; REVIEW;

ANIMALS; CELL ADHESION MOLECULES; CLINICAL TRIALS; ENZYME INHIBITORS; HUMANS; HYDROXAMIC ACIDS; METALLOENDOPEPTIDASES; PANCREATIC NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0032233724     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340050063     Document Type: Article

References (108)

1. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP (1995) Incidence, treatment and survival in 13560 patients with pancreatic cancer: An epidemiological study in the West Midlands. Br J Surg 82:111-115
2. Russell RC (1990) Surgical resection for cancer of the pancreas. Baillieres Clin Gastroenterol 4:889-916
3. Trede M, Schwall G, Saeger HD (1990) Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 211:447-458.
4. Gall FP, Kessler H, Hermanek P (1991) Surgical treatment of ductal pancreatic carcinoma. Eur J Surg Oncol 17:173-181
5. Andren-Sandberg A, Ahren B, Tranberg KG, Bengmark S (1991) Surgical treatment of pancreatic cancer. The Swedish experience. Int J Pancreatol 9:145-151
6. Edge SB, Schmieg R Jr, Rosenlof JL, Wilhelm MC (1993) Pancreas cancer resection outcome in American University centers in 1989-1990. Cancer 71:3502-3508
7. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J (1993) One hundred and forty-five consecutive pancreatoduodenectomies without mortality. Ann Surg 217:430-438
8. Nagakawa T, Konishi I, Higashino Y, Ueno K, Ohta T, Kayahara M, Ueda N, Maeda K, Miyazaki I (1989) The spread and prognosis of carcinoma in the region of the pancreatic head. Jpn J Surg 19:510-518
9. Nagakawa T, Kayahara M, Ueno K, Ohta T, Konishi I, Ueda N, Miyazaki I (1992) A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer 69:930-935
10. Mollenhauer J, Roether I, Kern HF (1987) Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. Pancreas 2:14-24
11. Hart IR, Goode NT, Wilson RE (1989) Molecular aspects of the metastatic cascade. Biochim Biophys Acta 989:65-84
12. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67-68
13. Liotta LA, Stetler-Stevenson WG (1991) Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 51 (Suppl):5054s-5059s
14. Martinez-Hernandez A, Amenta PS (1983) The basement membrane in pathology. Lab Invest 48:656-677
15. Forster SJ, Talbot IC, Clayton DG, Gritchley DR (1986) Tumour basement membrane laminin in adenocarcinoma of rectum: An immunohistochemical study of biological and clinical significance. Int J Cancer 37:813-817
16. Charpin C, Lissitzky JC, Jacquemier J, Lavaut MN, Kopp F, Pourreau-Schneider N, Martin PM, Toga M (1986) Immunohistochemical detection of laminin in 98 human breast carcinomas: A light and electron microscopic study. Hum Pathol 17:355-365
17. Lee CS, Montebello J, Georgiou T, Rode J (1994) Distribution of type IV collagen in pancreatic adenocarcinoma and chronic pancreatitis. Int J Exp Pathol 75:79-83
18. Wang Z-H, Manabe T, Ohshio G, Imamura T, Yoshimura T, Suwa H, Ishigami S, Kyogoku T (1994) Immunohistochemical study of heparan sulfate proteoglycan in adenocarcinomas of the pancreas. Pancreas 9:758-763
19. Cottam DW, Rees RC (1993) Regulation of matrix metalloproteinases: Their role in tumor invasion and metastasis (review). Int J Oncol 2:861-872
20. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65
21. Will H, Hinzman B (1995) cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231:602-608
22. Takino T, Sato H, Shinagawa A, Seiki M (1995) Indentification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J Biol Chem 270:23013-23020
23. Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C (1996) Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56:944-949
24. McCroskery PA, Richards JF, Harris ED (1975) Purification and characterisation of a collagenase extracted from rabbit tumours. Biochem J 152:131-142
25. Nethery A, O'Grady RL (1989) Identification of a metalloproteinase co-purifying with rat tumour collagenase and the characteristics of fragments of both enzymes. Biochim Biophys Acta 994:149-160
26. Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 4:121-125
27. Pei D, Majmudar G, Weiss SJ (1994) Hydrolytic activation of a breast carcinoma-cell derived serpin by human stromelysin-3. J Biol Chem 269:25849-25855
28. Yamagata S, Ito Y, Tanaka R, Shimizu S (1988) Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis. Biochem Biophys Res Comm 151:158-162
29. Yamagata S, Tanaka R, Ito Y, Shimizu S (1989) Gelatinases of murine metastatic tumour cells. Biochem Biophys Res Comm 158:228-234
30. Bernhard EJ, Muschel RJ, Hughes EN (1990) Mr 92000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 50:3872-3877
31. Van-Der-Stappen JWJ, Hendriks T, Wobbes T (1990) Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int J Cancer 45:1071-1078
32. Wirl G, Frick J (1979) Collagenase - a marker enzyme in human bladder cancer? Urol Res 7:103-108
33. Campo E, Merino MJ, Tavassoli FA, Charonis AS, Stetler-Stevenson WG, Liotta LA (1992) Evaluation of basement membrane components and the 72 kDa type IV collagenase in serous tumors of the ovary. Am J Surg Pathol 16:500-507
34. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR (1991) Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer 49:666-672
35. Waxman J, Wasan H (1992) The Architecture of cancer. BMJ 305:1306-1307
36. Matrisian LM, Bowden GT (1990) Stromelysin/transin and tumor progression. Semin Cancer Biol 1:107-115
37. Matrisian LM, McDonnell S, Miller DB, Navre M, Seftor EA, Hendrix MJC (1991) The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. Am J Med Sci 302:157-162
38. Polette M, Clavel C, Birembaut P, De-Clerck YA (1993) Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Pathol Res Pract 189:1052-1057
39. Muller D, Wolf C, Abecassis J, Millon R, Engelmann A, Bronner G, Rouyer N, Rio MC, Eber M, Methlin G, et al (1993) Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 53:165-169
40. Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesch H, Dumont P, Eber M, Abecassis J (1991) Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 48:550-556
41. Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A, Kossakowska AE (1992) Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 66:1188-1194
42. Urbanski SJ, Edwards DR, Hershfield N, Huchcroft SA, Shaffer E, Sutherland L, Kossakowska AE (1993) Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn Mol Pathol 2:81-89
43. Baker T, Tickle S, Wasan H, Docherty A, Isenberg D, Waxman J (1994) Serum metalloproteinases and their inhibitors: Markers for malignant potential. Br J Cancer 70:506-512
44. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K, Tryggvason K (1992) Localisation of messenger RNA for Mr 72000 and 92000 type IV collagenases in human skin cancers by in-situ hybridisation. Cancer Res 52:1336-1341
45. Poulsom R, Hanby AM, Pignatelli M, Jeffery RE, Longcroft JM, Rogers L, Stamp GWH (1993) Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 46:429-436
46. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffrey RE, Longcroft JM, Rogers L, Stamp GWH (1992) Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 141:389-396
47. Monteagudo C, Merino MJ, San-Juan J, Liotta LA, Stetler-Stevenson WG (1990) Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 136:585-592
48. Levy AT, Cioce V, Sobel ME, Garbisa S, Grigioni WF, Liotta LA, Stetler-Stevenson WG (1991) Increased expression of the Mr 72000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 51:439-444
49. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limache JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704
50. Okada Y, Tsuchiya H, Shimizu H, Tomita K, Nakanishi I, Sato H, Seiki M, Yamashita K, Hayakawa T (1990) Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor a. Biochem Biophys Res Commun 171:610-617
51. Overall CM, Wrana JL, Sodek J (1989) Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 264:1860-1870
52. Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG (1990) Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J Clin Invest 86:1204-1210
53. He C, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, Goldberg GI (1989) Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 86:2632-2636
54. Ito N, Nagase H (1988) Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys 267:211-216
55. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T (1992) Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 267:21712-21719
56. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJP (1987) Stromelysin is an activator of procollagenase. Biochem J 248:265-268
57. Brown PD, Bloxidge RE, Stuart NS, Gatter KC, Carmichael J (1993) Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma. J Natl Cancer Inst 85:574-578
58. Emonard HP, Remade AG, Noel AC, Grimaud JA, Stetler-Stevenson WG, Foidart JM (1992) Tumor cell surface-associated binding site for the M(r) 72000 type IV collagenase. Cancer Res 52:5845-5848
59. Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJ (1992) The C-terminal domain of 72kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 283(Pt 3):637-641
60. Sato H, Takino T, Kinoshita T, Seiki M (1996) Membrane-type matrix metalloproteinase (MT-MMP) -1, -2, -3 are activator of gelatinase A/72kDa-type IV collagenase. In: Matrisian LM, Sloane BF (eds) Proteases and protease inhibitors: AACR Special Conference; 1996; Marrriott's Bay Point Resort, Panama City Beach, Florida, US; p A52
61. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338
62. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M (1996) Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393:101-104
63. Okumura Y, Sato H, Seiki M, Kido H (1997) Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator. FEBS Lett 402:181-184
64. Pei D, Weiss SJ (1995) Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375:244-247
65. Sellers A, Murphy G, Meikle MC, Reynolds JJ (1979) Rabbit bone collagenase inhibitor blocks the activity of other neutral metalloproteinases. Biochem Biophys Res Commun 87:581-587
66. Stetler-Stevenson WG, Krutzsch HC, Liotta LA (1989) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374-17378
67. Uria JA, Ferrando AA, Velasco G, Freije JMP, Lopez-Otin C (1994) Structure and expression in breast tumours of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res 54:2091-2094
68. Shiu YE, Greene J, Wang M, Xiao G, Liu YE (1996) Loss of expression of TIMP-4, a novel human tissue inhibitor of metalloproteinase, in human breast cancer malignant progression. In: Matrisian LM, Sloane BF (eds) Proteases and protease inhibitors: AACR Special Conference; 1996; Marriott's Bay Point Resort, Panama City Beach, Florida, US; p A10
69. Cawston TE, Galloway WA, Mercer E, Murphy G, Reynolds JJ (1981) Purification of rabbit bone inhibitor of collagenase. Biochem J 195:159-165
70. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI (1989) SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213-17221
71. DeClerck YA, Yean T-D, Ratzkin BJ, Lu HS, Langley KE (1989) Purification and charaterisation of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 264:17445-17453
72. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelm S, He C (1989) Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 86:8207-8211
73. Ponton A, Coulombe B, Skup D (1991) Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res 51:2138-2143
74. Hynes RO (1992) Integrins: versatility, modulation and signalling in cell adhesion. Cell 69:11-25
75. Davis GE (1992) Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Commun 182;1025-1031
76. Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integtin αvβ3. Cell 85:683-693
77. Riikonen T, Westermarck J, Koivisto L, Broberg A, Kahari VM, Heino J (1995) Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alphal(I) gene expression. J Biol Chem 270:13548-13552
78. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH (1995) Cooperative signalling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 129:867-879
79. Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M (1988) Tenascin interferes with fibronectin action. Cell 53:383-390
80. Tremble P, Chiquet-Ehrismann R, Werb Z (1994) The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 5:439-453
81. Tremble PM, Damsky CH, Werb Z (1992) Fibronectin fragments, but not intact fibronectin, signalling through the fibronectin receptor induce metalloproteinase gene expression in fibroblasts. Matrix Suppl 1:212-214
82. Taniguchi S, Iwamura T, Katsuki T (1992) Correlation between spontaneous metastatic potential and type 1 collagenolytic activity in a human pancreatic cell line (SUIT-2) and sublines. Clin Exp Metastasis 10:259-266
83. Zucker S, Lysik RM, Wieman J, Wilkie DP, Lane B (1985) Diversity of human pancreatic cancer cell proteinases: Role of cell membrane metalloproteinases in collagenolysis and cytolysis. Cancer Res 45:6168-6178
84. Zucker S, Wieman JM, Lysik RM, Wilkie D, Ramamurthy NS, Golub LM, Lane B (1987) Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells. Cancer Res 47:1608-1614
85. Zucker S, Moll UM, Lysik RM, DiMassimo EI, Stetler-Stevenson WG, Liotta LA, Schwedes JW (1990) Extraction of type-IV collagenase/gelatinase from plasma membranes of hu-man cancer cells. Int J Cancer 45:1137-1142
86. Zucker S, Moll UM, Lysik RM, DiMassimo EI, Schwedes JW, Liotta LA (1992) Extraction of type IV collagenase/gelatinase from plasma membranes of human pancreatic cancer cells. Matrix Suppl 1:411
87. Bramhall SR, Stamp GWH, Dunn J, Lemoine NR, Neoptolemos JP (1996) Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinase (TIMP1) in pancreatic and ampullary disease. Br J Cancer 73:972-978
88. Bramhall SR, Neoptolemos JP, Stamp GWH, Lemoine NR (1997) Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma. J Pathol 182:347-355
89. Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P (1995) Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Pro Nat Acad Sci USA 92:2730-2734
90. Saarialho-Kere UK, Crouch EC, Parks WC (1995) Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol 105:190-196
91. Gress TM, Muller-Pillasch F, Lerch MM, Friess H, Buchler M, Adler G (1995) Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer 62:407-413
92. Koshiba T, Hosotani R, Wada M, Miyamoto Y, Fujimoto K, Lee J-U, Doi R, Arii S, Imamura M (1998) Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer 82:642-650
93. Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF (1988) Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonisation by murine B16-F10 melanoma cells. Cancer Res 48:5539-5545
94. Alvarez OA, Carmichael DF, DeClerck YA (1990) Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 82:589-595
95. DeClerck YA, Yean T-D, Lu HS, Ting J, Langley KE (1991) Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/ TIMP-2. J Biol Chem 266:3893-3899
96. Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler-Stevenson WG (1991) Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 83:775-779
97. Kawamata H, Kawai K, Kameyama S, Johnson MD, Stetler-Stevenson WG, Oyasu R (1995) Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma. Int J Cancer 63:680-687
98. DeClerck YA, Hammani K, Kohn D, Imren S (1996) Tissue inhibitors of matrix metalloproteinases in tumor growth. In: Matrisian LM, Sloane BF (eds) Proteases and pro tease inhibitors: AACR Special Conference; 1996; Marriott's Bay Point Resort, Panama City Beach, Florida, US
99. Khokha R (1996) Tumor development in TIMP-1 transgenic mice. In: Matrisian LM, Sloane BF (eds) Proteases and protease inhibitors: AACR Special Conference; 1996; Marriott's Bay Point Resort, Panama City Beach, Florida, US
100. Connolly JM, Liu X-H, Rose DP (1996) Type IV collagenase activities in invasive human breast cancer cell lines and their regulation by linoleic acid-derived 12-hydroxyeicosatetraenoic acid (12-HETE). In: Matrisian LM, Sloane BF (eds) Proteases and protease inhibitors: AACR Special Conference; 1996; Marriott's Bay Point Resort, Panama City Beach, Florida, US; p A28
101. Bramhall SR, Williams D, Youngs D, Neoptolemos JP (1996) Type IV collagenase expression is integral to MMP induced in-vitro invasion and is inhibited by BB2516 and BB94 (abstract). Gut 39:257
102. Sledge GW Jr, Qulali M, Goulet R, Bone EA, Fife R (1995) Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 87:1546-1550
103. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR (1993) A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 53:2087-2091
104. Watson SA, Morris TM, Robinson G, Crimmin MJ, Brown PD, Hardcastle JD (1995) Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res 55:3629-3633
105. Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD (1996) Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB94). Cancer Res 56:2815-2822
106. Docherty AJP, Birch ML, Chander S, Cockett MI, Millican TA, Mountain A, Willmott N, Murphy G, Hart I, Mahadevan V, An Z, Hoffman RM, Anderson IC, Shipp MA, Teicher BA (1996) Metalloproteinase inhibitors in the treatment of cancer. In: Matrisian LM, Sloane BF (eds) Pro teases and protease inhibitors: AACR Special Conference; 1996; Marriott's Bay Point Resort, Panama City Beach, Florida, US
107. Evans J, Bramhall S, Carmichael J, Daniel F, Imrie C, Johnson C, Neoptolemos J, Stark A (1996) A phase II study of marimastat in advanced pancreatic cancer (abstract 239). Ann Oncol 7:47
108. Moore M (1996) Activity of gemcitabine in patients with advanced pancreatic carcinoma. Cancer 78:633-638